Heterologous gain-of-function is the paper's core strength. AfTFT1 expressed in Komagataella phaffii (AOX1 promoter, 72 h methanol induction) yielded 10.4 ± 3.2 µg lichenase-released glucose per mg alcohol-insoluble residue versus 1.9 ± 3.2 in wild type, corroborated by anti-MLG immunofluorescence, a Megazyme mixed-linkage β-glucan assay, and lichenase/HPAEC-PAD profiling . The product's DP2:DP3 molar ratio (2.9:1) closely tracks native A. fumigatus wall MLG (3.4:1; 0.11 ± 0.01 µg DP2 and 0.04 ± 0.01 µg DP3 per mg AIR, absent from undigested controls) , and glycosyl-linkage analysis of the DP2/DP3 fractions supports genuine mixed-linkage structure. Host choice is defensible: K. phaffii previously supported functional expression of a plant GT2 synthase (AtCSLC4 producing the xyloglucan β-1,4-backbone) .
Uncertainty flag: the wild-type SD (3.2) exceeds its own mean, and the record documents only technical replicates (n=3 control, n=15 AfTFT1); biological culture-to-culture variability is unquantified, so the ~5.5-fold effect size could shift with true biological replication.
Aligning an AlphaFold-predicted AfTFT1 model to the HvCSLF6 cryo-EM structure identified four corresponding residues. Individually humanizing them, I551Y produced only DP2 while C524I, I519S, and G392D retained both DP2 and DP3 . Replacing the entire 548–558 switch motif with the HvCSLF6 sequence abolished detectable MLG by both immunofluorescence and HPAEC-PAD .
| AfTFT1 variant | Targeted region | Lichenase products | Anti-MLG signal |
|---|---|---|---|
| Wild-type AfTFT1 | — | DP2 + DP3 (2.9:1) | + |
| G392D | Membrane pore | DP2 + DP3 | + |
| I519S | Membrane pore | DP2 + DP3 | + |
| C524I | Membrane pore | DP2 + DP3 | + |
| I551Y | Switch motif | DP2 only | + |
| SM→HvCSLF6 | Whole switch motif (548–558) | None detected | − |
All variants expressed less MLG-derived oligosaccharide than wild type, and stability, localization, catalytic activity, and processivity were not assayed — so linkage-choice conclusions are confounded by protein-level effects, as the authors themselves acknowledge.
Maximum-likelihood phylogenetics (MAFFT L-INS-i, trimAl, ModelFinder, IQ-TREE 2, 1,000–5,000 ultrafast bootstraps) placed AfTFT1 in a distinct fungal GT2 lineage spanning Eurotiomycetes, Sordariomycetes, Leotiomycetes, Dothideomycetes, and Pucciniomycetes, sharing 70–96% identity with AfTFT1 and clearly separated from characterized plant and bacterial MLG synthases . This placement is methodologically solid, but the activity of every homolog remains a prediction.
What would change the conclusion: a linkage map of the AfTFT1 product lacking β-(1,3)-interrupted β-(1,4)-glucan, or purified AfTFT1 failing to synthesize DP2/DP3 in defined liposomes, would falsify the synthase assignment. Author names were absent from the supplied records, so author-review links could not be generated.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.